News dalla rete ITA

7 Dicembre 2022



EiraMed to export blood and plasma devices to EAEUEiraMed LLP producing blood transfusion devices has lowered the country’s dependence on the import of such equipment since it was opened in 2019EiraMed LLP is preparing to supply devices for blood components to Russia, Belarus, and Kyrgyzstan, which are currently waiting for approval to access the EAEC market."The demand of medical facilitates in Astana, Almaty, Shymkent, and regional blood centers for transfusion devices has been fully met, which allowed for reducing the imports of such products," Mikhail Shakhmatov, production director at EiraMed, told reporters.Shakhmatov said that the domestic products can withstand competition due to their high quality and lower price, 7-12% below the average price for similar products of other manufacturers.EiraMed was put into operation in January 2019 in Astana - New City special economic zone. EiraMed produces 23 types of medical devices of its own design and under the patents of the world brands such as Macopharma (France) and Haemonetics Corporation (USA). The plant can produce 250,000 products per year.The project raised  7 million euros from private investors in the European Union and a  loan from RBK Bank worth 3.2 billion tenge provided through a credit line of the Damu Fund, which is due in 2026. (ICE ALMATY)

Fonte notizia: INTERFAX